XML 58 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense Stock-based compensation expense for the years ended December 31, 2024, 2023, and 2022, included as a component of “Selling, general and administrative expenses,” was as follows:
 202420232022
Stock-based compensation$145.9 $123.5 $117.8 
Tax benefit recognized in net earnings$24.8 $20.4 $18.6 
Schedule of Weighted-Average Assumptions of Share-Based Compensation
The weighted-average fair value of options granted in 2024, 2023, and 2022 were calculated using the following weighted average assumptions:

 202420232022
Weighted-average fair value ($)173.21 130.23 116.55 
Risk-free interest rate (%)4.15 3.76 2.19 
Expected option life (years)5.735.615.63
Expected volatility (%)25.54 26.05 24.59 
Expected dividend yield (%)0.51 0.63 0.55 
The fair value of performance-based restricted stock awards subject to a market modifier granted in 2024 was determined using the following weighted average assumptions:
 2024
Weighted-average grant date fair value ($)563.00 
Risk-free interest rate (%)4.30 
Expected term (years)2.80
Expected volatility (%)20.12 
Expected dividend yield (%)0.50 
Schedule of Stock Options Share-Based Compensation Activity
The following table summarizes stock option activities, with respect to the Company’s share-based compensation plans, for the years ended December 31, 2024 and 2023:

 Number of optionsWeighted-average exercise priceWeighted-average remaining contractual term (years)Aggregate intrinsic value
Outstanding at December 31, 20222.985 $312.34   
Granted0.383 $432.77   
Exercised(0.593)$246.77   
Canceled(0.087)$425.80   
Outstanding at December 31, 20232.688 $340.89 6.00$549.1 
Granted0.286 $553.79   
Exercised(0.422)$298.04   
Canceled(0.072)$468.72   
Outstanding at December 31, 20242.480 $368.57 5.37$384.4 
Exercisable at December 31, 20241.688 $316.77 4.03$342.9 
Schedule of Restricted Stock Award Activity
The following table summarizes the Company’s restricted stock award activity during 2024 and 2023:

 Number of sharesWeighted-average grant date fair value
Nonvested at December 31, 20220.445 $416.00 
Granted0.280 $439.72 
Vested(0.202)$406.36 
Forfeited(0.083)$434.87 
Nonvested at December 31, 20230.440 $431.96 
Granted0.402 $552.94 
Vested(0.229)$445.87 
Forfeited(0.058)$522.46 
Nonvested at December 31, 20240.555 $515.77